2 | Challenge Your Peers Session: How Can Pharma Companies Effectively Manage the Technical Challenges Associated with OT Migration and Site Spin-offs During M&A Activities to Ensure Seamless Integration and Operational Continuity?

2 | Challenge Your Peers Session

Thursday, October 01

04:45 PM - 05:45 PM

Live in Berlin

Less Details

What are the key technical challenges faced during OT migration when spinning off from a parent company like Novartis, and how can these challenges be overcome?
How do technical considerations and challenges shape the decision-making process during M&A activity, particularly when it comes to site spin-offs?
What strategies can be employed to ensure that the spin-off of sites is handled efficiently without disrupting ongoing operations or compromising system integrity?
How do you ensure alignment between multiple sites, especially when they are transitioning through technical complexities in an M&A environment?
What are the best practices for maintaining business continuity and minimizing downtime during technical transitions that arise from site spin-offs in an M&A context?

Workshop

Get Agenda

BOOK NOW